Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84


Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018.

Hadland SE, Cerdá M, Earlywine JJ, Krieger MS, Anderson TS, Marshall BDL.

JAMA Pediatr. 2020 Jan 21. doi: 10.1001/jamapediatrics.2019.5526. [Epub ahead of print] No abstract available.


Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults.

Alinsky RH, Zima BT, Rodean J, Matson PA, Larochelle MR, Adger H Jr, Bagley SM, Hadland SE.

JAMA Pediatr. 2020 Jan 6:e195183. doi: 10.1001/jamapediatrics.2019.5183. [Epub ahead of print]


Through the Haze: What Clinicians Can Do to Address Youth Vaping.

Hadland SE, Chadi N.

J Adolesc Health. 2020 Jan;66(1):10-14. doi: 10.1016/j.jadohealth.2019.10.009. No abstract available.


Opioid Prescribing Patterns and Subsequent Overdose.

Hadland SE, Bagley SM.

JAMA Pediatr. 2019 Dec 16. doi: 10.1001/jamapediatrics.2019.4885. [Epub ahead of print] No abstract available.


Challenges and new horizons in substance use and addictions: Overview of the 2019 conference of the Association of Multidisciplinary Education and Research in Substance use and Addiction (AMERSA).

Mountain-Ray S, Simeone C, Hadland SE, Finnell DS, Northup R, MacLane-Baeder D.

Subst Abus. 2019;40(4):389-391. doi: 10.1080/08897077.2019.1695039. Epub 2019 Dec 6.


Youth Access to Naloxone: The Next Frontier?

Chadi N, Hadland SE.

J Adolesc Health. 2019 Nov;65(5):571-572. doi: 10.1016/j.jadohealth.2019.08.005. No abstract available.


Interpreting trends in paediatric opioid prescribing.

Hadland SE, Degenhardt L.

Lancet Child Adolesc Health. 2019 Dec;3(12):839-840. doi: 10.1016/S2352-4642(19)30325-6. Epub 2019 Oct 8. No abstract available.


Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.

Bagley SM, Larochelle MR, Xuan Z, Wang N, Patel A, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY.

Ann Emerg Med. 2020 Jan;75(1):29-38. doi: 10.1016/j.annemergmed.2019.07.030. Epub 2019 Oct 4.


Treatment for Nicotine Use Disorder Among Medicaid-Enrolled Adolescents and Young Adults.

Chadi N, Rodean J, Earlywine JJ, Zima BT, Bagley SM, Levy S, Hadland SE.

JAMA Pediatr. 2019 Sep 23. doi: 10.1001/jamapediatrics.2019.3200. [Epub ahead of print] No abstract available.


Prevalence and Correlates of Depressive Symptomology among Young Adults Who Use Prescription Opioids Non-medically.

Bouvier BA, Kinnard EN, Yedinak JL, Li Y, Elston B, Green TC, Hadland SE, Marshall BDL.

J Psychoactive Drugs. 2019 Nov-Dec;51(5):441-452. doi: 10.1080/02791072.2019.1654151. Epub 2019 Aug 14.


How Clinicians Caring for Youth Can Address the Opioid-Related Overdose Crisis.

Hadland SE.

J Adolesc Health. 2019 Aug;65(2):177-180. doi: 10.1016/j.jadohealth.2019.05.008. No abstract available.


Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs.

Goldman JE, Krieger MS, Buxton JA, Lysyshyn M, Sherman SG, Green TC, Bernstein E, Hadland SE, Marshall BDL.

Subst Abus. 2019;40(4):519-526. doi: 10.1080/08897077.2019.1616245. Epub 2019 Jun 17.


Opioid agonist treatment and the process of injection drug use initiation.

Mittal ML, Jain S, Sun S, DeBeck K, Milloy MJ, Hayashi K, Hadland SE, Werb D.

Drug Alcohol Depend. 2019 Apr 1;197:354-360. doi: 10.1016/j.drugalcdep.2018.12.018. Epub 2019 Jan 22.


Understanding the implications of the "vaping epidemic" among adolescents and young adults: A call for action.

Chadi N, Hadland SE, Harris SK.

Subst Abus. 2019;40(1):7-10. doi: 10.1080/08897077.2019.1580241. Epub 2019 Mar 18.


Alcohol Use Disorder: A Pediatric-Onset Condition Needing Early Detection and Intervention.

Hadland SE, Knight JR, Harris SK.

Pediatrics. 2019 Mar;143(3). pii: e20183654. doi: 10.1542/peds.2018-3654. Epub 2019 Feb 19. No abstract available.


Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.

Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M.

JAMA Netw Open. 2019 Jan 4;2(1):e186007. doi: 10.1001/jamanetworkopen.2018.6007. Erratum in: JAMA Netw Open. 2019 Mar 1;2(3):e191625.


International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering.

Darnall BD, Juurlink D, Kerns RD, Mackey S, Van Dorsten B, Humphreys K, Gonzalez-Sotomayor JA, Furlan A, Gordon AJ, Gordon DB, Hoffman DE, Katz J, Kertesz SG, Satel S, Lawhern RA, Nicholson KM, Polomano RC, Williamson OD, McAnally H, Kao MC, Schug S, Twillman R, Lewis TA, Stieg RL, Lorig K, Mallick-Searle T, West RW, Gray S, Ariens SR, Sharpe Potter J, Cowan P, Kollas CD, Laird D, Ingle B, Julian Grove J, Wilson M, Lockman K, Hodson F, Palackdharry CS, Fillingim RB, Fudin J, Barnhouse J, Manhapra A, Henson SR, Singer B, Ljosenvoor M, Griffith M, Doctor JN, Hardin K, London C, Mankowski J, Anderson A, Ellsworth L, Davis Budzinski L, Brandt B, Hartley G, Nickels Heck D, Zobrosky MJ, Cheek C, Wilson M, Laux CE, Datz G, Dunaway J, Schonfeld E, Cady M, LeDantec-Boswell T, Craigie M, Sturgeon J, Flood P, Giummarra M, Whelan J, Thorn BE, Martin RL, Schatman ME, Gregory MD, Kirz J, Robinson P, Marx JG, Stewart JR, Keck PS, Hadland SE, Murphy JL, Lumley MA, Brown KS, Leong MS, Fillman M, Broatch JW, Perez A, Watford K, Kruska K, Sophia You D, Ogbeide S, Kukucka A, Lawson S, Ray JB, Wade Martin T, Lakehomer JB, Burke A, Cohen RI, Grinspoon P, Rubenstein MS, Sutherland S, Walters K, Lovejoy T.

Pain Med. 2019 Mar 1;20(3):429-433. doi: 10.1093/pm/pny228. No abstract available.


Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014.

Chatterjee A, Larochelle MR, Xuan Z, Wang N, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY, Bagley SM.

Drug Alcohol Depend. 2019 Jan 1;194:28-31. doi: 10.1016/j.drugalcdep.2018.09.020. Epub 2018 Oct 25.


Use of rapid fentanyl test strips among young adults who use drugs.

Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, Rich JD, Hadland SE, Green TC, Marshall BDL.

Int J Drug Policy. 2018 Nov;61:52-58. doi: 10.1016/j.drugpo.2018.09.009. Epub 2018 Oct 18.


Adolescents and Perceived Riskiness of Marijuana: Why Care?

Chadi N, Hadland SE.

J Adolesc Health. 2018 Oct;63(4):377-378. doi: 10.1016/j.jadohealth.2018.07.023. No abstract available.


Reduced Opioid Marketing Could Limit Prescribing Information for Physicians-Reply.

Hadland SE, Cerdá M, Marshall BDL.

JAMA Intern Med. 2018 Oct 1;178(10):1426-1427. doi: 10.1001/jamainternmed.2018.4366. No abstract available.


Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.

Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT.

JAMA Pediatr. 2018 Nov 1;172(11):1029-1037. doi: 10.1001/jamapediatrics.2018.2143.


Opioid deaths in Ontario, Canada.

Hadland SE, Kertesz SG.

BMJ. 2018 Aug 29;362:k3537. doi: 10.1136/bmj.k3537. No abstract available.


Evaluating the Feasibility of Incorporating In-Person Interpreters on Family-Centered Rounds: A QI Initiative.

Cheston CC, Alarcon LN, Martinez JF, Hadland SE, Moses JM.

Hosp Pediatr. 2018 Aug;8(8):471-478. doi: 10.1542/hpeds.2017-0208.


Increased burden of suicidality among young street-involved sex workers who use drugs in Vancouver, Canada.

Barker B, Hadland SE, Dong H, Shannon K, Kerr T, DeBeck K.

J Public Health (Oxf). 2019 Jun 1;41(2):e152-e157. doi: 10.1093/pubmed/fdy119.


Addressing Adolescents' and Young Adults' Substance Use Disorders.

Chadi N, Bagley SM, Hadland SE.

Med Clin North Am. 2018 Jul;102(4):603-620. doi: 10.1016/j.mcna.2018.02.015. Review.


Tighter prescribing regulations drive illicit opioid sales.

Hadland SE, Beletsky L.

BMJ. 2018 Jun 13;361:k2480. doi: 10.1136/bmj.k2480. No abstract available.


Association of State Alcohol Policies With Alcohol-Related Motor Vehicle Crash Fatalities Among US Adults.

Naimi TS, Xuan Z, Sarda V, Hadland SE, Lira MC, Swahn MH, Voas RB, Heeren TC.

JAMA Intern Med. 2018 Jul 1;178(7):894-901. doi: 10.1001/jamainternmed.2018.1406.


Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.

Hadland SE, Cerdá M, Li Y, Krieger MS, Marshall BDL.

JAMA Intern Med. 2018 Jun 1;178(6):861-863. doi: 10.1001/jamainternmed.2018.1999. No abstract available.


Stigma associated with medication treatment for young adults with opioid use disorder: a case series.

Hadland SE, Park TW, Bagley SM.

Addict Sci Clin Pract. 2018 May 7;13(1):15. doi: 10.1186/s13722-018-0116-2.


High willingness to use rapid fentanyl test strips among young adults who use drugs.

Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, Green TC, Hadland SE, Marshall BDL.

Harm Reduct J. 2018 Feb 8;15(1):7. doi: 10.1186/s12954-018-0213-2.


The Effectiveness of Internet- and Field-Based Methods to Recruit Young Adults Who Use Prescription Opioids Nonmedically.

Marshall BDL, Green TC, Elston B, Yedinak JL, Hadland SE, Clark MA.

Subst Use Misuse. 2018 Aug 24;53(10):1688-1699. doi: 10.1080/10826084.2018.1425725. Epub 2018 Jan 24.


Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.

Carney BL, Hadland SE, Bagley SM.

Pediatr Rev. 2018 Jan;39(1):43-45. doi: 10.1542/pir.2017-0153. Review. No abstract available.


Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically.

Bouvier BA, Waye KM, Elston B, Hadland SE, Green TC, Marshall BDL.

Drug Alcohol Depend. 2018 Feb 1;183:73-77. doi: 10.1016/j.drugalcdep.2017.10.023. Epub 2017 Dec 7.


Socioeconomic factors associated with cessation of injection drug use among street-involved youth.

Chang DC, Hadland SE, Nosova E, Wood E, Kerr T, DeBeck K.

Subst Abuse Treat Prev Policy. 2017 Dec 7;12(1):50. doi: 10.1186/s13011-017-0136-z.


Variation in the 12-Month Treatment Trajectories of Children and Adolescents After a Diagnosis of Depression.

Joyce NR, Schuler MS, Hadland SE, Hatfield LA.

JAMA Pediatr. 2018 Jan 1;172(1):49-56. doi: 10.1001/jamapediatrics.2017.3808.


Mental Health Spending and Intensity of Service Use Among Individuals With Diagnoses of Eating Disorders Following Federal Parity.

Huskamp HA, Samples H, Hadland SE, McGinty EE, Gibson TB, Goldman HH, Busch SH, Stuart EA, Barry CL.

Psychiatr Serv. 2018 Feb 1;69(2):217-223. doi: 10.1176/ Epub 2017 Nov 15.


The Alternative Quality Contract: Impact on Service Use and Spending for Children With ADHD.

Joyce NR, Huskamp HA, Hadland SE, Donohue JM, Greenfield SF, Stuart EA, Barry CL.

Psychiatr Serv. 2017 Dec 1;68(12):1210-1212. doi: 10.1176/ Epub 2017 Nov 15.


Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically.

Soipe AI, Taylor LE, Abioye AI, Green TC, Hadland SE, Marshall BDL.

J Adolesc Health. 2018 Jan;62(1):114-117. doi: 10.1016/j.jadohealth.2017.07.018. Epub 2017 Oct 25.


Alcohol Policies and Alcohol-Involved Homicide Victimization in the United States.

Naimi TS, Xuan Z, Coleman SM, Lira MC, Hadland SE, Cooper SE, Heeren TC, Swahn MH.

J Stud Alcohol Drugs. 2017 Sep;78(5):781-788.


Cessation of Injecting and Preceding Drug Use Patterns Among a Prospective Cohort of Street-Involved Youth.

Hadland SE, Wood E, Nosova E, Kerr T, DeBeck K.

J Adolesc Health. 2017 Nov;61(5):612-618. doi: 10.1016/j.jadohealth.2017.05.029. Epub 2017 Sep 1.


Industry Payments to Physicians for Opioid Products, 2013-2015.

Hadland SE, Krieger MS, Marshall BDL.

Am J Public Health. 2017 Sep;107(9):1493-1495. doi: 10.2105/AJPH.2017.303982.


Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder.

Bagley SM, Hadland SE, Carney BL, Saitz R.

J Addict Med. 2017 Nov/Dec;11(6):415-416. doi: 10.1097/ADM.0000000000000348.


Injection drug use and overdose among young adults who use prescription opioids non-medically.

Liebling EJ, Green TC, Hadland SE, Marshall BDL.

Addict Behav. 2018 Jan;76:20-26. doi: 10.1016/j.addbeh.2017.07.017. Epub 2017 Jul 18.


Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.

Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR.

JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745.


Adolescent Frequent Heavy Drinking From 1991-2015.

Welsh JW, Knight JR, Hadland SE.

Pediatrics. 2017 Jun;139(6). pii: e20170932. doi: 10.1542/peds.2017-0932. No abstract available.


Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis.

Evans TI, Liebling EJ, Green TC, Hadland SE, Clark MA, Marshall BDL.

J Addict Med. 2017 Jul/Aug;11(4):266-272. doi: 10.1097/ADM.0000000000000318.


Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.

Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD.

Harm Reduct J. 2017 Feb 20;14(1):13. doi: 10.1186/s12954-017-0139-0.


Trajectories of Substance Use Frequency among Adolescents Seen in Primary Care: Implications for Screening.

Hadland SE, Copelas SH, Harris SK.

J Pediatr. 2017 May;184:178-185. doi: 10.1016/j.jpeds.2017.01.033. Epub 2017 Feb 10.


Alcohol Policies and Alcohol-Related Motor Vehicle Crash Fatalities Among Young People in the US.

Hadland SE, Xuan Z, Sarda V, Blanchette J, Swahn MH, Heeren TC, Voas RB, Naimi TS.

Pediatrics. 2017 Mar;139(3). pii: e20163037. doi: 10.1542/peds.2016-3037. Epub 2017 Feb 13.

Supplemental Content

Loading ...
Support Center